128 related articles for article (PubMed ID: 21350000)
21. Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments.
González A; Alonso-González C; González-González A; Menéndez-Menéndez J; Cos S; Martínez-Campa C
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209857
[TBL] [Abstract][Full Text] [Related]
22. Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy.
Fasano M; Della Corte CM; Viscardi G; Di Liello R; Paragliola F; Sparano F; Iacovino ML; Castrichino A; Doria F; Sica A; Morgillo F; Colella G; Tartaro G; Cappabianca S; Testa D; Motta G; Ciardiello F
Ther Adv Med Oncol; 2021; 13():1758835920949418. PubMed ID: 33767760
[TBL] [Abstract][Full Text] [Related]
23. Auto-HMM-LMF: feature selection based method for prediction of drug response via autoencoder and hidden Markov model.
Emdadi A; Eslahchi C
BMC Bioinformatics; 2021 Jan; 22(1):33. PubMed ID: 33509079
[TBL] [Abstract][Full Text] [Related]
24. Targeting the Extra-Cellular Matrix-Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors.
Lorusso G; Rüegg C; Kuonen F
Front Oncol; 2020; 10():1231. PubMed ID: 32793493
[TBL] [Abstract][Full Text] [Related]
25. Activation PDGFR-α/AKT Mediated Signaling Pathways in Oral Squamous Cell Carcinoma by Mesenchymal Stem/Stromal Cells Promotes Anti-apoptosis and Decreased Sensitivity to Cisplatin.
Wang J; Cui R; Clement CG; Nawgiri R; Powell DW; Pinchuk IV; Watts TL
Front Oncol; 2020; 10():552. PubMed ID: 32411595
[TBL] [Abstract][Full Text] [Related]
26. Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.
Mehta M; Griffith J; Panneerselvam J; Babu A; Mani J; Herman T; Ramesh R; Munshi A
Int J Radiat Biol; 2021; 97(8):1109-1120. PubMed ID: 32052681
[TBL] [Abstract][Full Text] [Related]
27. EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling.
Sato S; Vasaikar S; Eskaros A; Kim Y; Lewis JS; Zhang B; Zijlstra A; Weaver AM
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31661464
[TBL] [Abstract][Full Text] [Related]
28. Investigational multitargeted kinase inhibitors in development for head and neck neoplasms.
Sola AM; Johnson DE; Grandis JR
Expert Opin Investig Drugs; 2019 Apr; 28(4):351-363. PubMed ID: 30753792
[TBL] [Abstract][Full Text] [Related]
29. Tracking Tumor Colonization in Xenograft Mouse Models Using Accelerator Mass Spectrometry.
Hum NR; Martin KA; Malfatti MA; Haack K; Buchholz BA; Loots GG
Sci Rep; 2018 Oct; 8(1):15013. PubMed ID: 30302019
[TBL] [Abstract][Full Text] [Related]
30. Concurrent palliative external radiotherapy with sorafenib or doxorubicin for bulky differentiated thyroid carcinoma: A case report.
Cortés-Mateus KS; Holub K; Racca F; Grau JJ; Capdevila J
Oncol Lett; 2018 Sep; 16(3):4085-4089. PubMed ID: 30128032
[TBL] [Abstract][Full Text] [Related]
31. Study of Crocin & Radiotherapy-induced Cytotoxicity and Apoptosis in the Head and Neck Cancer (HN-5) Cell Line.
Vazifedan V; Mousavi SH; Sargolzaei J; Soleymanifard S; Fani Pakdel A
Iran J Pharm Res; 2017; 16(1):230-237. PubMed ID: 28496478
[TBL] [Abstract][Full Text] [Related]
32. RET Signaling in Prostate Cancer.
Ban K; Feng S; Shao L; Ittmann M
Clin Cancer Res; 2017 Aug; 23(16):4885-4896. PubMed ID: 28490466
[No Abstract] [Full Text] [Related]
33. Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study.
Wang T; Hu P; Li B; Zhang JP; Cheng YF; Liang YM
Onco Targets Ther; 2017; 10():1809-1819. PubMed ID: 28367064
[TBL] [Abstract][Full Text] [Related]
34. Anti-tumor and anti-invasion effects of a combination of 4-methylumbelliferone and ionizing radiation in human fibrosarcoma cells.
Saga R; Monzen S; Chiba M; Yoshino H; Nakamura T; Hosokawa Y
Oncol Lett; 2017 Jan; 13(1):410-416. PubMed ID: 28123575
[TBL] [Abstract][Full Text] [Related]
35. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
Schmitz S; Machiels JP
Curr Treat Options Oncol; 2016 Jul; 17(7):37. PubMed ID: 27262711
[TBL] [Abstract][Full Text] [Related]
36. Effect of postoperative radiotherapy for squamous cell cancer of the breast in a surveillance epidemiology and end results population-based study.
Wu SG; Sun JY; Liu WM; Li FY; Lin HX; He ZY
Oncotarget; 2016 Mar; 7(9):10684-93. PubMed ID: 26863453
[TBL] [Abstract][Full Text] [Related]
37. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma.
Takahashi Y; Lee J; Pickering C; Bell D; Jiffar TW; Myers JN; Hanna EY; Kupferman ME
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1926-34. PubMed ID: 26752332
[TBL] [Abstract][Full Text] [Related]
38. Molecular biology and immunology of head and neck cancer.
Guo T; Califano JA
Surg Oncol Clin N Am; 2015 Jul; 24(3):397-407. PubMed ID: 25979390
[TBL] [Abstract][Full Text] [Related]
39. Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb.
Ma W; Yu J; Qi X; Liang L; Zhang Y; Ding Y; Lin X; Li G; Ding Y
Oncotarget; 2015 Jun; 6(18):15984-94. PubMed ID: 25961730
[TBL] [Abstract][Full Text] [Related]
40. CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance.
Ventelä S; Sittig E; Mannermaa L; Mäkelä JA; Kulmala J; Löyttyniemi E; Strauss L; Cárpen O; Toppari J; Grénman R; Westermarck J
Oncotarget; 2015 Jan; 6(1):144-58. PubMed ID: 25474139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
